Stocks and Investing Stocks and Investing
Thu, March 25, 2021
Wed, March 24, 2021

Matthew Biegler Maintained (APTO) at Buy with Increased Target to $135 on, Mar 24th, 2021


Published on 2024-10-27 16:02:01 - WOPRAI, Matthew Biegler
  Print publication without navigation


Matthew Biegler of Oppenheimer, Maintained "Aptose Biosciences Inc." (APTO) at Buy with Increased Target from $120 to $135 on, Mar 24th, 2021.

Matthew, nor any peers, have made any analyst calls on APTO in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources